Fierce Biotech March 24, 2023
Welcome to this week’s Chutes & Ladders, our roundup of hirings, firings and retirings throughout the industry. Please send the good word—or the bad—from your shop to Max Bayer or Gabrielle Masson, and we will feature it here at the end of each week.
Ex-Seagen leader Siegall to be new CEO of Purdue University spinout less than a year after arrest
MorphImmune
Co-founder and former CEO of Seagen Clay Siegall is back in the biopharma world less than a year after he was arrested and booked on fourth-degree domestic assault charges. He’s been hired as the new CEO of MorphImmune, a new biotech spun out of Purdue University.
The company said in a...
Today's Sponsors
Today's Sponsor